Implications of Recent EU and UK Court Decisions in the Pharmaceutical Sector

Emily MacKenzie, Barrister at Brick Court Chambers, will join Libby Amos of Arnold & Porter's Future Pharma Forum to recap how challenges to pharmaceutical decisions may be brought to the European and domestic courts. Emily will provide a summary of recent European Court and English Court decisions in the pharmaceutical area, and together Libby and Emily will explore the implications for pharmaceutical companies.

Topics

• How to bring challenges to the European Court.
• The interplay of domestic proceedings.
• Summary of recent European Court decisions, including:
• Shire on orphan market exclusivity, and
• Astellas on the role of the Concerned Member State.
• Summary of recent English Court decisions, including Napp on the Article 10(3) hybrid-abridged procedure.
• Changes in the Notice to Applicants regarding RDP, including the "reverse combination" principle.
• The implications for pharmaceutical companies.